FIELD: medicine.
SUBSTANCE: invention relates to medicine and vaginal suppositories containing composition of recombinant proteins made of aminoacid sequences of protein E7 of human papilloma virus of 16 and 18 types accordingly, which are covalently linked to aminoacid sequence of heat shock protein, molecular weight 70 kDa from M.tuberculosis, cocoa butter and solid fat of type A, polyethylene glycol 1500, emulsifier.
EFFECT: invention doubles average time of preparation availability in organism compared to injection introduction, reduced duration of treatment course and exclusion of injection method of introduction.
1 cl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MEDICATION FOR TREATMENT OF UTERUS NECK DISEASES, ASSOCIATED WITH HUMAN PAPILLOMA VIRUS, IN FORM OF VAGINAL SUPPOSITORY | 2010 |
|
RU2438703C1 |
| MUCOSAL VACCINE FOR IMMUNE THERAPY OF DISEASES CAUSED BY HUMAN PAPILLOMA VIRUSES, AND RELATED THERAPY (VERSIONS) | 2008 |
|
RU2377305C1 |
| MEDICINE FOR TREATMENT OF UTERUS NECK DISEASES, ASSOCIATED WITH HUMAN PAPILLOMA VIRUS, IN FORM OF VAGINAL CAPSULES | 2010 |
|
RU2438702C1 |
| DRUG FOR HUMAN PAPILLOMA VIRUS ASSOCIATED DISEASES OF UTERINE NECK, PRESENTED IN FORM OF SOLUTION FOR VAGINAL IRRIGATIONS, KIT AND METHOD FOR PREPARING | 2010 |
|
RU2438652C1 |
| RECOMBINANT PROTEIN COMPOSITION, METHOD FOR PREPARING SUCH COMPOSITION, PHARMACEUTICAL KIT OF REAGENTS FOR IMMUNOTHERAPY AND PROPHYLACTIC VACCINATION OF TUMOR DISEASES IN ANUS-GENITAL SPHERE, METHOD FOR IMMUNOTHERAPY AND PROPHYLACTIC VACCINATION BASED ON THEREOF | 2002 |
|
RU2229307C1 |
| RECOMBINANT FUSED PROTEIN, PREPARATION FOR IMMUNOTHERAPY BASED ON THEREOF AND METHOD FOR IMMUNOTHERAPY OF RELAPSING LARYNX PAPILLOMATOSIS | 2005 |
|
RU2290204C1 |
| METHOD FOR TREATING INFECTION CAUSED WITH HUMAN PAPILLOMA VIRUS (HPV) | 2001 |
|
RU2282461C2 |
| METHOD FOR MICROBIOLOGICAL SYNTHESIS OF HYBRID PROTEIN E7-HSP70 (VERSIONS) | 2013 |
|
RU2546917C1 |
| METHOD FOR PREPARING SUPPOSITORY BASE | 2006 |
|
RU2318867C1 |
| IMMUNOGENIC COMPOSITION BASED ON RECOMBINANT PROTEINS E6-CBD AND E7-CBD FOR THE TREATMENT OF MALIGNANT NEOPLASMS ASSOCIATED WITH HUMAN PAPILLOMAVIRUS TYPE 16 | 2023 |
|
RU2805482C1 |
